SparX Group has Initiated a Phase 1 Trial of its First Organ

SparX Group has Initiated a Phase 1 Trial of its First Organically Developed Candidate, SPX-101

/PRNewswire/ -- With a mission of "Bolstering human immunity by utilizing empowered antibody therapies", the SparX Group is rapidly becoming a significant...

Related Keywords

Mount Prospect , Illinois , United States , Chicago , Cayman Islands , Dong Zhu , Sparx Group , Gui Dong Zhu , Sparx Biopharmaceutical ,

© 2025 Vimarsana